Achillion Regains Compliance With NASDAQ Listing Rules
<p>December 16, 2009 (FinancialWire) — Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, reported that it received …